Answers are grounded in this paper and cite their sources.
Narrative review demonstrates 19F-NMR screening and structural profiling for protein targets in infectious diseases, highlighting its role in accelerating fragment-based drug discovery.
(19)F-NMR has proved to be a valuable tool in fragment-based drug discovery. Its applications include screening libraries of fluorinated fragments, assessing competition among elaborated fragments and identifying the binding poses of promising hits. By observing fluorine in both the ligand and the target protein, useful information can be obtained on not only the binding pose but also the dynamics of ligand-protein interactions. These applications of (19)F-NMR will be illustrated in this review with studies from our fragment-based drug discovery campaigns against protein targets in parasitic and infectious diseases.
No takes yet. Share an insight, caveat, or question.
Norton et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: